Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Jungsil Ro
Woman Max 99 years
Jungsil Ro
Update Il y a 4 ans
Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib
Phase Ib part: ▪ Primary objective: To demonstrate the recommended dose of the combination of paclitaxel, gemcitabine, and sunitinib (sutene®) (PGS) as preoperative chemotherapy in patien...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jungsil Ro
Update Il y a 4 ans
Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab
The investigators address the clinical efficacy of continuing lapatinib treatment combined with vinorelbine after the progression of both trastuzumab and lapatinib treatment compared with ...
Country
Korea, Republic of
organs
None
Specialty
None
Opened trial
More information
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
Primary objective is to evaluate the response rates and clinical benefits of letrozole + goserelin in premenopausal patients versus letrozole alone in postmenopausal patients with metastat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jungsil Ro, Ph,D
Update Il y a 4 ans
Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients
The purpose of this study is to evaluate the overall response rate of Genexol-PM compared with paclitaxel (cremophor-based paclitaxel) as palliative chemotherapy in anthracycline-pretreate...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD
Update Il y a 4 ans
Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)
Primary objectives : 1. To evaluate the recommended dose of the combination of paclitaxel, gemcitabine, and lapatinib (Tykerb®) (PGT) as preoperative chemotherapy in patients with HER2 po...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
This is an open labeled phase III randomized trial. The patients with clinical stage II and III will undergo mammotome biopsy of breast tumor for histologic diagnosis, immunohistochemical ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
To evaluate the pathologic complete response rate to preoperative administration of Paclitaxel, Gemcitabine, and Trastuzumab (HerceptinÒ) (PGH)
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, M.D
Update Il y a 4 ans
Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
To evaluate the response rate of capecitabine and irinotecan combination therapy in patients with metastatic breast cancer
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD, PhD
Update Il y a 4 ans
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
To evaluate the overall response rate of gemcitabine and vinorelbine combination (GV) and gemcitabine followed by vinorelbine (G⇒V) when used as palliative therapy in patients with stage I...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro
Update Il y a 4 ans
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
This study is a multicenter, randomized study, open-label, phase III study.The efficacy of irinotecan and capecitabine combination will be superior to capecitabine alone in term of progres...
Country
None
organs
None
Specialty
None
unknown
More information
1
2
Next